Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secukinumab”

195 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 195 results

Testing effectiveness (Phase 2)Study completedNCT02594098
What this trial is testing

Secukinumab for Treatment of Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Icahn School of Medicine at Mount Sinai 41
Testing effectiveness (Phase 2)Study completedNCT03041038
What this trial is testing

The Efficacy and Safety of Secukinumab in Patients With Ichthyoses

Who this might be right for
IchthyosisAutosomal Recessive Congenital IchthyosisLamellar Ichthyosis+3 more
Northwestern University 20
Testing effectiveness (Phase 2)Study completedNCT03568136
What this trial is testing

Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis

Who this might be right for
Dermatitis, AtopicEczema, AtopicNeurodermatitis, Atopic
GWT-TUD GmbH 22
Not applicableStudy completedNCT07130331
What this trial is testing

Efficacy and Influencing Factors of Secukinumab in Patients With Axial Spondyloarthritis

Who this might be right for
Axial Spondylarthritis (axSpA)Secukinumab
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 200
Large-scale testing (Phase 3)Study completedNCT02474082
What this trial is testing

Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 202
Not applicableLooking for participantsNCT06399432
What this trial is testing

Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors

Who this might be right for
Psoriasis
University Hospitals Cleveland Medical Center 36
Large-scale testing (Phase 3)Study completedNCT03906136
What this trial is testing

AScalate: Treat-to-target in Axial Spondyloarthritis

Who this might be right for
Axial Spondyloarthritis
Novartis Pharmaceuticals 304
Large-scale testing (Phase 3)Study completedNCT01892436
What this trial is testing

Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 460
Large-scale testing (Phase 3)Study completedNCT04102007
What this trial is testing

The Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or Ixekizumab

Who this might be right for
Plaque Psoriasis
AbbVie 244
Testing effectiveness (Phase 2)Ended earlyNCT03791060
What this trial is testing

Secukinumab for NLD (Cosentyx) in Patients With Necrobiosis Lipoidica Diabeticorum (NLD)

Who this might be right for
Necrobiosis Lipoidica Diabeticorum
Beth Israel Deaconess Medical Center 4
Testing effectiveness (Phase 2)Study completedNCT01537432
What this trial is testing

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Who this might be right for
Psoriasis, Plaque-type Psoriasis
Novartis Pharmaceuticals 36
Large-scale testing (Phase 3)Study completedNCT05569174
What this trial is testing

Study of Efficacy and Safety of AIN457/Secukinumab in Patients With Rotator Cuff Tendinopathy

Who this might be right for
Tendinopathy
Novartis Pharmaceuticals 62
Testing effectiveness (Phase 2)WithdrawnNCT04274166
What this trial is testing

Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Study completedNCT03553823
What this trial is testing

Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab

Who this might be right for
Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 40
Post-approval studies (Phase 4)Active Not RecruitingNCT05622708
What this trial is testing

Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission

Who this might be right for
Non-radiographic Axial Spondyloarthritis
Novartis Pharmaceuticals 240
Post-approval studies (Phase 4)Study completedNCT04080661
What this trial is testing

Therapeutic Drug Monitoring of Secukinumab in Psoriasis Patients.

Who this might be right for
Psoriasis Vulgaris
University Hospital, Ghent 82
Large-scale testing (Phase 3)Study completedNCT01752634
What this trial is testing

Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 397
Post-approval studies (Phase 4)Study completedNCT03623867
What this trial is testing

PsA Secukinumab XCT Structural Progression Study

Who this might be right for
Psoriatic Arthritis
Chinese University of Hong Kong 40
Not applicableStudy completedNCT05677542
What this trial is testing

Secukinumab (Cosentyx®) Effectiveness in Axial Spondyloarthritis and Psoriatic Arthritis Patients Using Artificial Intelligence (SpAINET): Spanish Multicenter, Retrospective, Real World Evidence Study

Who this might be right for
Axial SpondyloarthritisPsoriatic Arthritis
Novartis Pharmaceuticals 758
Testing effectiveness (Phase 2)Ended earlyNCT01478360
What this trial is testing

Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 46
Load More Results